Zeposia helps cognitive function

Published 09 August

Zeposia (ozanimod) can help to stabilise or even improve cognition in people with multiple sclerosis (MS) according to a phase 3 clinical trial.

Zeposia is taken orally and works by keeping immune cells within the lymph nodes, preventing them crossing into the brain and causing damage.

The researchers said early, long-term treatment showed the best results as cognition was better preserved in people who had higher brain volume to begin with, before much damage had been done.